| Autor: |
Akgün, H., Berk, B., Demir Erol, D., Mercanoglu, G., Bayrak, Ö.F., Çag Layan, B., Aksan Kurnaz, I. |
| Přispěvatelé: |
Akgün, H., Berk, B., Demir Erol, D., Mercanoglu, G., Bayrak, Ö.F., Çag Layan, B., Aksan Kurnaz, I., Yeditepe Üniversitesi |
| Jazyk: |
angličtina |
| Rok vydání: |
2009 |
| Předmět: |
|
| Popis: |
New series of [(2-chloroethyl)ureido] benzoic acids (compounds 3-8) and nitric oxide releasing derivatives of [(2-chloroethyl)ureido] benzoic acid esters (compounds 9-14) were synthesized as potential anti-cancer agents. These compounds were screened for their anti-proliferative activities on A549 (human lung carcinoma) cells and for their cytotoxic effects on L929 (mouse fibroblast) cells. The compounds 3-8 exhibited mild cytotoxic effects on L929 cells (cell viability from 100% to 85% - 90% only) whereas they had very little antiproliferative activities towards A549 lung carcinoma cells. On the other hand, compounds 10, 11, and 13 had some growth inhibition activity in A549 (human lung carcinoma) cells. Among them, compounds 11 and 13 exhibited better anti-proliferative activities towards A549 cells, but also appeared to be cytotoxic towards L929 cells. In this group, the compound 10 with (1-(2-nitrooxyethyl)-3-[(2-chloroethyl)ureido]benzoate) structure appeared to have very weak anti-neoplastic activity towards A549 cells, with very little cytotoxic activity towards fibroblasts at physiological concentrations. Therefore, this compound is a better candidate for a potential anti-cancer therapy for non-small cell lung carcinomas. However, further studies are required in order to show applicability and effectiveness in animal models for this type of cancer. © TÜBİTAK. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
